Walleye Capital LLC Staar Surgical CO Call Options Transaction History

Walleye Capital LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	SELL	$29.97 - $47.42 $1.32 Million - $2.08 Million	-43,900 Reduced 82.52%	9,300 $345,000
Q2 2024 Aug 14, 2024	BUY	$38.07 - $52.25 $1.63 Million - $2.23 Million	42,700 Added 406.67%	53,200 $2.53 Million
Q1 2024 May 15, 2024	BUY	$27.67 - $39.61 $188,156 - $269,348	6,800 Added 183.78%	10,500 $401,000
Q4 2023 Feb 14, 2024	SELL	$30.6 - $43.78 $201,960 - $288,948	-6,600 Reduced 64.08%	3,700 $115,000
Q3 2023 Nov 14, 2023	SELL	$39.39 - $58.12 $248,157 - $366,156	-6,300 Reduced 37.95%	10,300 $413,000
Q2 2023 Aug 14, 2023	BUY	$50.45 - $72.82 $837,470 - $1.21 Million	16,600 New	16,600 $872,000
Q3 2022 Nov 14, 2022	BUY	$70.55 - $111.58 $973,590 - $1.54 Million	13,800 New	13,800 $974,000

255

47.8M

427K

206K

Ticker STAA
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 48,038,300
Market Cap $1.35B
Description
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatis...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.